JP2008524261A5 - - Google Patents

Download PDF

Info

Publication number
JP2008524261A5
JP2008524261A5 JP2007547054A JP2007547054A JP2008524261A5 JP 2008524261 A5 JP2008524261 A5 JP 2008524261A5 JP 2007547054 A JP2007547054 A JP 2007547054A JP 2007547054 A JP2007547054 A JP 2007547054A JP 2008524261 A5 JP2008524261 A5 JP 2008524261A5
Authority
JP
Japan
Prior art keywords
protein
seq
influenza
composition
fusion protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007547054A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008524261A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/046662 external-priority patent/WO2006069262A2/en
Publication of JP2008524261A publication Critical patent/JP2008524261A/ja
Publication of JP2008524261A5 publication Critical patent/JP2008524261A5/ja
Pending legal-status Critical Current

Links

JP2007547054A 2004-12-21 2005-12-21 インフルエンザウイルスタンパク質の組成物およびその使用方法 Pending JP2008524261A (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US63825404P 2004-12-21 2004-12-21
US63835004P 2004-12-21 2004-12-21
US64506705P 2005-01-19 2005-01-19
US65320705P 2005-02-15 2005-02-15
US66687805P 2005-03-31 2005-03-31
US68207705P 2005-05-18 2005-05-18
US74120205P 2005-11-30 2005-11-30
PCT/US2005/046662 WO2006069262A2 (en) 2004-12-21 2005-12-21 Compositions of influenza viral proteins and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2008524261A JP2008524261A (ja) 2008-07-10
JP2008524261A5 true JP2008524261A5 (enExample) 2009-02-12

Family

ID=36272492

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007547054A Pending JP2008524261A (ja) 2004-12-21 2005-12-21 インフルエンザウイルスタンパク質の組成物およびその使用方法

Country Status (9)

Country Link
EP (1) EP1831259A2 (enExample)
JP (1) JP2008524261A (enExample)
AU (2) AU2005319141B8 (enExample)
BR (1) BRPI0519705A2 (enExample)
CA (1) CA2593746A1 (enExample)
MX (1) MX2007007586A (enExample)
NZ (1) NZ556004A (enExample)
SG (1) SG160424A1 (enExample)
WO (1) WO2006069262A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1841785A2 (en) * 2005-01-19 2007-10-10 Vaxinnate Corporation Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response
EP3011969A1 (en) 2006-03-07 2016-04-27 Vaxinnate Corporation Compositions that include hemagglutinin, methods of making and methods of use thereof
WO2007127290A2 (en) * 2006-04-24 2007-11-08 Protelix, Inc. Method for producing viral vaccine and therapeutic peptide antigens
US8604178B2 (en) * 2006-09-18 2013-12-10 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses
EP1925318A1 (en) * 2006-11-20 2008-05-28 Paul-Ehrlich-Institut Recombinant modified vaccinia virus Ankara (MVA)-based vaccine for the avian flu
WO2008157419A2 (en) * 2007-06-13 2008-12-24 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Immunogenic peptides of influenza virus
MX2010001284A (es) 2007-08-02 2010-08-31 Biondvax Pharmaceuticals Ltd Vacunas contra la influenza con multiepitope multimerico.
GB0720250D0 (en) * 2007-10-17 2007-11-28 Univ Edinburgh Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof
WO2009062348A1 (en) 2007-11-14 2009-05-22 Institute Of Microbiology, Chinese Academy Of Sciences Methods for inhibiting influenza virus infection and their drugs
WO2009128952A2 (en) 2008-04-18 2009-10-22 Vaxinnate Corporation Compositions of papillomavirus proteins and methods of use
WO2010115229A1 (en) 2009-04-09 2010-10-14 The University Of Melbourne Immunogenic composition and uses thereof
MX348663B (es) * 2009-09-08 2017-05-26 Inst Tecnologico Estudios Superiores Monterrey Proceso de producción de una vacuna recombinante, dicha vacuna expresable en cepas de escherichia coli y su uso para combatir la influenza a h1ni1 brote 2009.
JP2013516469A (ja) * 2010-01-06 2013-05-13 ヴァクシネイト コーポレイション 高齢者に保護免疫を提供するための方法及び組成物
HUE037157T2 (hu) 2010-01-21 2018-08-28 Univ Arkansas Vakcinavektorok, és eljárások immunválaszok fokozására
AU2011230491A1 (en) * 2010-03-26 2012-10-18 Emergent Product Development Gaithersburg Inc. Ectodomains of influenza Matrix 2 protein, expression system, and uses thereof
GB201009273D0 (en) * 2010-06-03 2010-07-21 Glaxosmithkline Biolog Sa Novel vaccine
CN103189072B (zh) 2010-09-22 2018-02-09 因纳瓦克私人有限公司 免疫刺激方法
AU2011360572B2 (en) 2011-02-22 2017-03-02 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
US8932598B2 (en) 2012-08-28 2015-01-13 Vaxinnate Corporation Fusion proteins and methods of use
WO2014070848A1 (en) * 2012-11-05 2014-05-08 Georgia State University Research Foundation Universal influenza vaccine based on heterologous multiple m2e proteins
RU2571944C1 (ru) * 2014-10-17 2015-12-27 Общество с ограниченной ответственностью "НТфарма" Противогриппозная вакцина широкого спектра действия против птичьего гриппа а на основе эктодомена белка м2
ES3053993T3 (en) 2017-12-21 2026-01-28 Axelia Oncology Pty Ltd Optimised compounds
KR20220050873A (ko) 2019-06-26 2022-04-25 악셀리아 온콜로지 피티와이 리미티드 신규한 분자
WO2023028661A1 (en) * 2021-09-02 2023-03-09 Ena Respiratory Pty Ltd Formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101240547B1 (ko) * 2002-08-12 2013-03-08 더 카운실 오브 더 퀸스랜드 인스티튜트 오브 메디칼 리서어치 Ｔ-헬퍼 및 ｂ-세포 에피토프를 포함하는 신규한 면역원성리포펩타이드
RU2005131016A (ru) * 2003-03-07 2006-06-10 Мерк энд Ко., Инк. (US) Вакцина вируса гриппа

Similar Documents

Publication Publication Date Title
JP2008524261A5 (enExample)
KR101983989B1 (ko) 인플루엔자 바이러스 백신 및 이의 용도
JP7094103B2 (ja) インフルエンザウイルスワクチンおよびその使用
JP6285469B2 (ja) 呼吸器合胞体ウイルスの熱安定な融合前ｆタンパク質オリゴマーおよび免疫組成物におけるその使用
CN106661091B (zh) 流行性感冒病毒疫苗及其用途
US10398770B2 (en) Influenza virus hemagglutinin protein as a vaccine antigen
CA2913859A1 (en) Influenza virus vaccines and uses thereof
KR102379951B1 (ko) 인플루엔자 핵단백질 백신
US9896484B2 (en) Influenza virus recombinant proteins
TW202317600A (zh) 預防多種病毒感染的多價疫苗
AU2022366884A1 (en) Engineering antigen binding to, and orientation on, adjuvants for enhanced humoral responses and immunofocusing
Wang et al. Immunogenicity of a bovine viral diarrhea virus E2–C3d fusion protein containing a bovine homolog of C3d
JP2018052953A (ja) インフルエンザウイルスワクチンおよびその使用
CN118176204A (zh) 截短的流感神经氨酸酶及其使用方法
Choi et al. Immune response induced by the TAT-conjugated influenza M2e in mice
Van et al. Bio-functional enhancement of plant based-haemagglutinin by fusion with IgMFc
CN115197303A (zh) 一种s蛋白的受体结合结构域的突变体及其应用
US20220267382A1 (en) Chimeric hemagglutinin protein and a vaccine composition comprising the same
HK1236966B (en) Influenza virus vaccines and uses thereof
HK1236966A1 (en) Influenza virus vaccines and uses thereof
TH112180A (th) โปรตีนผสมชนิดใหม่ ๆ และการใช้โปรตีนเหล่านี้เพื่อการเตรียมวัคซีนต้านไวรัสตับอักเสบ ซี